Inclusion Criteria
•	Provision of signed and dated informed consent form
•	Stated willingness to comply with all study procedures and availability for the duration of the study
•	Male patients aged 18 years and older
•	In good general health as evidenced by medical history to be a candidate for curative-intent prostate cancer treatment 
•	Ability to receive pelvic radiotherapy and be willing to adhere to the SUPR-SABR regimen 
•	Previously untreated prostate cancer (with cytotoxic chemotherapy, cryotherapy, surgical or radiation therapy)
•	Localized adenocarcinoma of the prostate with the following features
	cT1-T2c
	Prostate specific antigen (PSA) < 20
	** Patients receiving a 5-alpha reductase inhibitor must have a PSA < 10
	Grade group 1-3
	Lymph node negative
	Negative for distant metastases
•	Prostate volume < 120 cc 
•	History and physical including a digital rectal exam 90 days prior to registration 
•	Eastern Cooperative Oncology Group (ECOG) performance status 0-2
•	Be able to undergo MRI prostate and pelvis as a component of radiation therapy (RT) planning
•	Bone and soft tissue imaging as clinically indicated (for unfavorable intermediate risk or symptomatic patients only) within 120 days prior to registration
•	International Prostate Symptom Score (IPSS) score =< 20 at time of initial history and physical with treating radiation oncologist

Exclusion Criteria
	Concurrent use of testosterone supplementation as it is contraindicated during prostate cancer treatment
	Known homozygous for ATM pathogenic mutation
	Prior pelvic RT 
	Pre-existing conditions or overall health status which disqualifies the patient from curative- intent RT. Patients with life expectancy less than 10 years are not eligible
	Prior or concurrent invasive pelvic malignancy (except non-melanomatous skin cancer) or lymphomatous or hematogenous malignancy, unless disease free for a minimum of 5 years
	Prior prostatectomy, cryotherapy, high-intensity focused ultrasound directed towards the prostate for any prostate disease or condition
